| MeSH term | MeSH ID | Detail |
|---|---|---|
| Weight Loss | D015431 | 56 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Neuroblastoma | D009447 | 66 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Leukemia | D007938 | 74 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Tao H et al. | OPG/RANK/RANKL axis as a potential therapeutic target for atrial fibrillation. | 2013 | Cardiology | pmid:23751957 |
| Xi L et al. | OPG/RANK/RANKL axis in atrial fibrillation. | 2013 | Cardiology | pmid:23752030 |
| Zhu Y et al. | Deciduous dental pulp stem cells are involved in osteoclastogenesis during physiologic root resorption. | 2013 | J. Cell. Physiol. | pmid:22674471 |
| Koide M et al. | Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice. | 2013 | Endocrinology | pmid:23291450 |
| Pacifici R | Osteoimmunology and its implications for transplantation. | 2013 | Am. J. Transplant. | pmid:23915249 |
| Albu A et al. | Bone metabolism regulators and arterial stiffness in postmenopausal women. | 2013 | Maturitas | pmid:23916080 |
| O'Sullivan EP et al. | A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. | 2013 | Metab. Clin. Exp. | pmid:22841521 |
| Benito-Martin A et al. | Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. | 2013 | PLoS ONE | pmid:24058411 |
| Lau CP et al. | Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. | 2013 | Connect. Tissue Res. | pmid:24060052 |
| Corrado A et al. | RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. | 2013 | J. Rheumatol. | pmid:23457386 |
| Koluman BU et al. | Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes. | 2013 | Clin. Nephrol. | pmid:23458176 |
| Sooampon S et al. | Transient receptor potential vanilloid-1 regulates osteoprotegerin/RANKL homeostasis in human periodontal ligament cells. | 2013 | J. Periodont. Res. | pmid:22587561 |
| Galli C et al. | GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces. | 2013 | Clin Oral Implants Res | pmid:22626030 |
| Wang Q et al. | The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women. | 2013 | Int. Immunopharmacol. | pmid:23856613 |
| Mogi M and Kondo A | The presence of RANKL-OPG complex in human osteosarcoma U2OS. | 2013 | J Immunoassay Immunochem | pmid:23859786 |
| Zappitelli T et al. | The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss. | 2013 | J. Bone Miner. Res. | pmid:23606335 |
| Zhou J et al. | [Effect of sinusoidal electromagnetic fields on rats femur tissue cultivation in vitro]. | 2013 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | pmid:23865319 |
| Gao L et al. | Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. | 2013 | J. Immunol. | pmid:23241890 |
| Brabnikova Maresova K et al. | Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes. | 2013 | Calcif. Tissue Int. | pmid:23247536 |
| Eren MA et al. | Association of parity with osteoprotegerin levels and atherosclerosis. | 2013 | Arch. Gynecol. Obstet. | pmid:23287888 |
| Ko GJ | A biomarker, osteoprotegerin, in patients undergoing hemodialysis. | 2013 | Korean J. Intern. Med. | pmid:24307839 |
| Lee JE et al. | Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients. | 2013 | Korean J. Intern. Med. | pmid:24307842 |
| Hartwich JE et al. | Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model. | 2013 | J. Pediatr. Surg. | pmid:23331792 |
| Naidu VG et al. | RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines. | 2013 | Chem. Biol. Interact. | pmid:23333834 |
| Yao Y et al. | Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats. | 2013 | Rheumatol. Int. | pmid:23334376 |
| Guerra-Menéndez L et al. | IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand. | 2013 | J Transl Med | pmid:24161214 |
| Montagnana M et al. | The role of osteoprotegerin in cardiovascular disease. | 2013 | Ann. Med. | pmid:23110639 |
| Giganti MG et al. | Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. | 2012 Oct-Dec | J. Biol. Regul. Homeost. Agents | pmid:23241117 |
| Heitzer E et al. | IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. | 2012 Nov-Dec | Pain Physician | pmid:23159968 |
| Nuño-Arana I et al. | Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. | 2012 Jul-Aug | Am. J. Hum. Biol. | pmid:22434650 |
| Varsavsky M et al. | Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. | 2012 Jul-Aug | J. Androl. | pmid:21903971 |
| Dalezis P et al. | Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. | 2012 Jan-Feb | In Vivo | pmid:22210719 |
| Ambroszkiewicz J et al. | [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. | 2012 Apr-Jun | Med Wieku Rozwoj | pmid:22971655 |
| Wang Y et al. | Curculigoside isolated from Curculigo orchioides prevents hydrogen peroxide-induced dysfunction and oxidative damage in calvarial osteoblasts. | 2012 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:22427460 |
| Tobón-Arroyave SI et al. | Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. | 2012 | J. Clin. Periodontol. | pmid:23039038 |
| Udomsuk L et al. | Impact of Pueraria candollei var. mirifica and its potent phytoestrogen miroestrol on expression of bone-specific genes in ovariectomized mice. | 2012 | Fitoterapia | pmid:23041523 |
| Yang Y et al. | [Association between osteoprotegerin gene polymorphisms and severe pre-eclampsia in Chinese women]. | 2012 | Zhonghua Fu Chan Ke Za Zhi | pmid:22455689 |
| Xiang G et al. | Change of plasma osteoprotegerin and its association with endothelial dysfunction before and after exercise in Hashimoto's thyroiditis with euthyroidism. | 2012 | Exp. Clin. Endocrinol. Diabetes | pmid:23070830 |
| Lekva T et al. | TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing's syndrome and related to bone turnover. | 2012 | Eur. J. Endocrinol. | pmid:22450549 |
| Ming LG et al. | [Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro]. | 2012 | Yao Xue Xue Bao | pmid:22512027 |
| Chaves MD et al. | Bovine hydroxyapatite (Bio-Oss(®)) induces osteocalcin, RANK-L and osteoprotegerin expression in sinus lift of rabbits. | 2012 | J Craniomaxillofac Surg | pmid:22513050 |
| Koole D et al. | Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease. | 2012 | Arterioscler. Thromb. Vasc. Biol. | pmid:22516062 |
| Boumans MJ et al. | Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. | 2012 | Ann. Rheum. Dis. | pmid:22072013 |
| Chen X et al. | Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts. | 2012 | Biol Trace Elem Res | pmid:22076734 |
| Robinson DE et al. | Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions. | 2012 | Biomaterials | pmid:22079008 |
| Aliprantis AO et al. | Transient muscle paralysis degrades bone via rapid osteoclastogenesis. | 2012 | FASEB J. | pmid:22125315 |
| Al-Sabbagh M et al. | Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health. | 2012 | J. Periodont. Res. | pmid:22126530 |
| Tanaka M et al. | Effect of Reveromycin A on experimental tooth movement in OPG-/- mice. | 2012 | J. Dent. Res. | pmid:22674934 |
| Yan J et al. | Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone. | 2012 | Am. J. Pathol. | pmid:22640808 |
| Kim S et al. | Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis. | 2012 | Diagn. Microbiol. Infect. Dis. | pmid:22647538 |
| Jørgensen L et al. | Osteoprotegerin is associated with hip fracture incidence: the Tromso Study. | 2012 | Int J Epidemiol | pmid:22538253 |
| Motovska Z et al. | Circulating osteoprotegerin and Dickkopf-1 changed significantly after surgical aortic valve replacement but remained without any significant differences after transcatheter aortic valve implantation. | 2012 | Int. J. Cardiol. | pmid:22592030 |
| Güncü GN et al. | Effect of inflammation on cytokine levels and bone remodelling markers in peri-implant sulcus fluid: a preliminary report. | 2012 | Cytokine | pmid:22592038 |
| Santos VR et al. | Partial- and full-mouth scaling and root planing in type 2 diabetic subjects: a 12-mo follow-up of clinical parameters and levels of cytokines and osteoclastogenesis-related factors. | 2012 | J. Periodont. Res. | pmid:21806617 |
| Oelzner P et al. | The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis. | 2012 | Rheumatol. Int. | pmid:20821212 |
| Hwang JJ et al. | Receptor activator of nuclear factor-κB ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients. | 2012 | J. Acquir. Immune Defic. Syndr. | pmid:22842843 |
| Liang W et al. | Icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line. | 2012 | Int. J. Mol. Med. | pmid:22842877 |
| Nanda KS et al. | Elevated circulating osteoprotegerin and reduced matrix-metalloprotease-9 in post-menopausal women with chronic Hepatitis C virus infection. | 2012 | Cytokine | pmid:22863720 |
| Fossmark R et al. | Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice. | 2012 | J. Cell. Biochem. | pmid:21882222 |
| Oka H et al. | Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue. | 2012 | J. Periodontol. | pmid:21910594 |
| Korzon-Burakowska A et al. | Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. | 2012 | Diabet. Med. | pmid:21913967 |
| Wilkison M et al. | Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection. | 2012 | Am. J. Pathol. | pmid:22626807 |
| Wang QP et al. | Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand. | 2012 | Bone | pmid:22634178 |
| Brunetti G et al. | Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene. | 2012 | Endocrine | pmid:22638612 |
| Lacey DL et al. | Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. | 2012 | Nat Rev Drug Discov | pmid:22543469 |
| Campia U et al. | Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque. | 2012 | Heart | pmid:22543836 |
| Choe WS et al. | Association between OPG, RANK and RANKL gene polymorphisms and susceptibility to acute coronary syndrome in Korean population. | 2012 | J. Genet. | pmid:22546829 |
| Canon J et al. | RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model. | 2012 | Breast Cancer Res. Treat. | pmid:22926264 |
| Shuid AN et al. | Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model. | 2012 | BMC Complement Altern Med | pmid:22967165 |
| Dougall WC | Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. | 2012 | Clin. Cancer Res. | pmid:22031096 |
| Sakai N et al. | Receptor activator of nuclear factor-κB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice. | 2012 | Hepatology | pmid:22031462 |
| Sanchez C et al. | Regulation of subchondral bone osteoblast metabolism by cyclic compression. | 2012 | Arthritis Rheum. | pmid:22034083 |
| Rimondi E et al. | Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. | 2012 | Invest New Drugs | pmid:21541705 |
| Li YQ et al. | Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone. | 2012 | Acta Pharmacol. Sin. | pmid:22120966 |
| Wei W et al. | Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:22315431 |
| Hulin-Curtis SL et al. | Tumour necrosis factor receptor superfamily member 11B polymorphisms and association with knee osteoarthritis in women. | 2012 | Int. J. Immunogenet. | pmid:22296645 |
| Fitzgerald O and Chandran V | Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. | 2012 | J. Rheumatol. | pmid:22298273 |
| Silva JA et al. | Periodontal disease-associated compensatory expression of osteoprotegerin is lost in type 1 diabetes mellitus and correlates with alveolar bone destruction by regulating osteoclastogenesis. | 2012 | Cells Tissues Organs (Print) | pmid:22301390 |
| Gradosova I et al. | Protective effect of amlodipine on rat bone tissue after orchidectomy. | 2012 | Pharmacology | pmid:22302040 |
| Kadoglou NP et al. | Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms. | 2012 | Regul. Pept. | pmid:22982141 |
| Feng Q et al. | [Effect of sonicated extracts of Porphyromonas gingivalis on receptor activator of NF-κB ligand and osteoprotegerin expression in periodontal ligament cells]. | 2012 | Zhonghua Kou Qiang Yi Xue Za Zhi | pmid:23302383 |
| Yilmaz Y and Eren F | Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis. | 2012 | Clin. Chim. Acta | pmid:22985537 |
| Yan J et al. | Spinal cord injury causes bone loss through peroxisome proliferator-activated receptor-γ and Wnt signalling. | 2012 | J. Cell. Mol. Med. | pmid:22947224 |
| Mlakar SJ et al. | Testing GSTP1 genotypes and haplotypes interactions in Slovenian post-/pre-menopausal women: novel involvement of glutathione S-transferases in bone remodeling process. | 2012 | Maturitas | pmid:22221655 |
| Kadkhodazadeh M et al. | Analysis of osteoprotegerin (OPG) gene polymorphism in Iranian patients with chronic periodontitis and peri-implantitis. A cross-sectional study. | 2012 | Eur J Oral Implantol | pmid:23304691 |
| Emanuele E et al. | Linking atherosclerosis to Alzheimer's disease: focus on biomarkers. | 2012 | Front Biosci (Elite Ed) | pmid:22201906 |
| Jacot W et al. | Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy. | 2012 | Breast Cancer Res. Treat. | pmid:22562178 |
| Chen B et al. | Canonical Wnt signaling is required for Panax notoginseng saponin-mediated attenuation of the RANKL/OPG ratio in bone marrow stromal cells during osteogenic differentiation. | 2012 | Phytomedicine | pmid:22818895 |
| Kaneko K et al. | Changes of serum soluble receptor activator for nuclear factor-κB ligand after glucocorticoid therapy reflect regulation of its expression by osteoblasts. | 2012 | J. Clin. Endocrinol. Metab. | pmid:22791764 |
| Çanga A et al. | Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction. | 2012 | J Cardiol | pmid:22727437 |
| Yoon WJ et al. | Sargachromanol G regulates the expression of osteoclastogenic factors in human osteoblast-like MG-63 cells. | 2012 | Food Chem. Toxicol. | pmid:22727857 |
| Miyaji Y et al. | Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. | 2012 | Pharm. Res. | pmid:22729371 |
| Crotti TN et al. | The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints. | 2012 | Arthritis Res. Ther. | pmid:23146195 |
| Yao Y et al. | [The effect of bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis]. | 2012 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:22934505 |
| Zhang M et al. | [The expression and significance of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in periapical cyst and periapical granuloma]. | 2012 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:22934488 |
| Tenta R et al. | Association between circulating levels of adiponectin and indices of bone mass and bone metabolism in middle-aged post-menopausal women. | 2012 | J. Endocrinol. Invest. | pmid:21606670 |
| Liu L et al. | [Effect of gradually induced disordered occlusion on the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in mandibular condylar cartilage of rats]. | 2012 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:22594224 |
| Histing T et al. | Increased osteoblast and osteoclast activity in female senescence-accelerated, osteoporotic SAMP6 mice during fracture healing. | 2012 | J. Surg. Res. | pmid:21571305 |
| Ostrowska Z et al. | Â Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa. | 2012 | Postepy Hig Med Dosw (Online) | pmid:23001207 |
| Taddei SR et al. | Experimental model of tooth movement in mice: a standardized protocol for studying bone remodeling under compression and tensile strains. | 2012 | J Biomech | pmid:23036306 |